Ticker
IRDCompany Name
OPUS GENETICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Earning Before Interest & Taxes (EBIT) | EBIT Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -58.27M | -377.89% | $ 15.42M |
3/31/2025 | $ -58.62M | -429.42% | $ 13.65M |
12/31/2024 | $ -57.53M | -523.4% | $ 10.99M |
9/30/2024 | $ -27.19M | -324.47% | $ 8.38M |
6/30/2024 | $ -14.09M | -85.68% | $ 16.45M |
3/31/2024 | $ -11.29M | -59.38% | $ 19.01M |
12/31/2023 | $ -9.97M | -52.36% | $ 19.05M |
9/30/2023 | $ 29.08M | 50.83% | $ 57.21M |
6/30/2023 | $ 18.97M | 41.91% | $ 45.27M |
3/31/2023 | $ 19.01M | 45.7% | $ 41.6M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBIT / Revenues
(=) EBIT %
EBIT % for OPUS GENETICS INC is calculated as follows: EBIT [ $ -6.37M ] / Revenues [ $ 1.15M ]
(=) EBIT % [ -553.94% ]
Minimum
Dec 31, 2021
Maximum
Sep 30, 2023
Average
Median
filtered constituents | 3.26K |
---|---|
min | -73.16% |
max | 83.08% |
average | 9.54% |
median | 9.01% |
std | 23.96% |